Physician profile
Jessica Guidi
NPI 1497175749
$47,619.55
in general payments reported to CMS, 2019-2025
3 companies · $6,872 in 2025
The $6,872 reported for 2025 was more than what 75% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,435 · 2023: $21K · 2024: $14K · 2025: $6,872.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $41K · Food and Beverage: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $41,062.50 |
| Food and Beverage | $122.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beckman Coulter, INC. | $41,062.50 | 2023-2025 | Access Bnp |
| Abbott Laboratories | $6,435.00 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $122.05 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Guidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.